Ball And Stick Collection (#4)

Prostaglandin E1 drug molecule F007 / 0178
Prostaglandin E1 (alprostadil, PGE1) erectile dysfunction drug, molecular model. PGE1 is a prostaglandin used in the treatment of erectile dysfunction

Ponatinib leukemia drug F007 / 0176
Ponatinib leukemia drug, molecular model. Ponatinib is approved for the treatment of chronic myelogenous leukemia. Atoms are represented as spheres and are colour-coded: hydrogen (white)

Pomalidomide cancer drug F007 / 0175
Pomalidomide cancer drug, molecular model. Pomalidomide is a derivative of the notorious drug thalidomide and inhibits angiogenesis, the formation of new blood vessels

Pomalidomide cancer drug F007 / 0174
Pomalidomide cancer drug, molecular model. Pomalidomide is a derivative of the notorious drug thalidomide and inhibits angiogenesis, the formation of new blood vessels

Pomalidomide cancer drug F007 / 0173
Pomalidomide cancer drug, molecular model. Pomalidomide is a derivative of the notorious drug thalidomide and inhibits angiogenesis, the formation of new blood vessels

Perampanel antiepileptic drug F007 / 0172
Perampanel antiepileptic drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red) and nitrogen (blue)

Perampanel antiepileptic drug F007 / 0171
Perampanel antiepileptic drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red) and nitrogen (blue)

Perampanel antiepileptic drug F007 / 0170
Perampanel antiepileptic drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red) and nitrogen (blue)

Ocriplasmin vitreomacular adhesion drug F007 / 0165
Ocriplasmin (microplasmin) vitreomacular adhesion drug, molecular model. Ocriplasmin is a protease enzyme that dissolves the proteins holding the eye vitreous and macula together

Omacetaxine mepesuccinate leukemia drug F007 / 0169
Omacetaxine mepesuccinate leukemia drug, molecular model. This drug inhibits protein synthesis and is used in the treatment of chronic myelogenous leukemia (CML)

Loxapine schizophrenia drug F007 / 0164
Loxapine schizophrenia drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), chlorine (green), oxygen (red) and nitrogen (blue)

Loxapine schizophrenia drug F007 / 0163
Loxapine schizophrenia drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), chlorine (green), oxygen (red) and nitrogen (blue)

Loxapine schizophrenia drug F007 / 0162
Loxapine schizophrenia drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), chlorine (green), oxygen (red) and nitrogen (blue)

Lomitapide hypercholesterolemia drug F007 / 0161
Lomitapide hypercholesterolemia drug, molecular model. Lomitapide is used in the treatment of homozygous familial hypercholesterolemia

Lixivaptan hyponatremia drug F007 / 0159
Lixivaptan hyponatremia drug, molecular model. Lixivaptan blocks vasopressin from binding the vasopressin 2 receptor, and is used to treat heart failure in hyponatremia patients

Lixivaptan hyponatremia drug F007 / 0158
Lixivaptan hyponatremia drug, molecular model. Lixivaptan blocks vasopressin from binding the vasopressin 2 receptor, and is used to treat heart failure in hyponatremia patients

Linaclotide irritable bowel syndrome drug F007 / 0156
Linaclotide irritable bowel syndrome drug, molecular model. Linaclotide is used for the treatment of abdominal pain in irritable bowel syndrome patients

Levodopa Parkinsons disease drug
Levodopa (L-DOPA) Parkinsons disease drug, molecular model. L-DOPA is a precursor of the catecholamine neurotransmitters dopamine

Hydrocodone opioid analgesic drug F007 / 0152
Hydrocodone opioid analgesic drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red) and nitrogen (blue)

Hydrocodone opioid analgesic drug F007 / 0151
Hydrocodone opioid analgesic drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red) and nitrogen (blue)

Hydrocodone opioid analgesic drug F007 / 0150
Hydrocodone opioid analgesic drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red) and nitrogen (blue)

Hydrocodone opioid analgesic drug F007 / 0149
Hydrocodone opioid analgesic drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red) and nitrogen (blue)

Glycerol phenylbutyrate drug molecule F007 / 0147
Glycerol phenylbutyrate urea cycle disorder drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey) and oxygen (red)

Glycerol phenylbutyrate drug molecule F007 / 0148
Glycerol phenylbutyrate urea cycle disorder drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey) and oxygen (red)

Enzalutamide prostate cancer drug F007 / 0146
Enzalutamide prostate cancer drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red), sulphur (yellow)

Enzalutamide prostate cancer drug F007 / 0145
Enzalutamide prostate cancer drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red), sulphur (yellow)

Dimethylfumarate multiple sclerosis drug F007 / 0143
Dimethylfumarate (DMF) multiple sclerosis drug, molecular model. Dimethylfumarate is used for multiple applications, including multiple sclerosis and psoriasis treatment

Dibenzanthracene hydrocarbon molecule F007 / 0142
Dibenzanthracene polycyclic aromatic hydrocarbon (PAH), molecular model. Dibenz(a, h)anthracene is an environmental pollutant and suspected to be carcinogenic, mutagenic and teratogenic

Dibenzanthracene hydrocarbon molecule F007 / 0141
Dibenzanthracene polycyclic aromatic hydrocarbon (PAH), molecular model. Dibenz(a, h)anthracene is an environmental pollutant and suspected to be carcinogenic, mutagenic and teratogenic

Delamanid tuberculosis drug F007 / 0140
Delamanid tuberculosis (TB) drug, molecular model. Delamanid interferes with the production of mycolic acid, an essential component of the Mycobacterium tuberculosis bacterium cell wall

Delamanid tuberculosis drug F007 / 0139
Delamanid tuberculosis (TB) drug, molecular model. Delamanid interferes with the production of mycolic acid, an essential component of the Mycobacterium tuberculosis bacterium cell wall

Cysteamine bitartrate drug molecule F007 / 0138
Cysteamine bitartrate Huntingtons disease drug, molecular model. Cysteamine increases the levels of the neuroprotective factor BDNF (brain-derived neurotrophic factor)

Cysteamine bitartrate drug molecule F007 / 0137
Cysteamine bitartrate Huntingtons disease drug, molecular model. Cysteamine increases the levels of the neuroprotective factor BDNF (brain-derived neurotrophic factor)

Corannulene polycyclic, molecular model F007 / 0135
Corannulene polycyclic aromatic hydrocarbon (PAH), molecular model. Corannulene is an environmental pollutant and suspected to be carcinogenic, mutagenic and teratogenic

Cobicistat HIV drug F007 / 0134
Cobicistat HIV drug, molecular model. Cobicistat is a booster drug that slows down the breakdown of other HIV medicines and therefore is used in the combination drug treatment of HIV

Cobicistat HIV drug F007 / 0133
Cobicistat HIV drug, molecular model. Cobicistat is a booster drug that slows down the breakdown of other HIV medicines and therefore is used in the combination drug treatment of HIV

Cobicistat HIV drug F007 / 0132
Cobicistat HIV drug, molecular model. Cobicistat is a booster drug that slows down the breakdown of other HIV medicines and therefore is used in the combination drug treatment of HIV

Carfilzomib cancer drug F007 / 0131
Carfilzomib cancer drug, molecular model. Carfilzomib is a proteasome inhibitor that is used in cancer treatment. Atoms are represented as spheres and are colour-coded: hydrogen (white)

Carfilzomib cancer drug F007 / 0130
Carfilzomib cancer drug, molecular model. Carfilzomib is a proteasome inhibitor that is used in cancer treatment. Atoms are represented as spheres and are colour-coded: hydrogen (white)

Carfilzomib cancer drug F007 / 0128
Carfilzomib cancer drug, molecular model. Carfilzomib is a proteasome inhibitor that is used in cancer treatment. Atoms are represented as spheres and are colour-coded: hydrogen (white)

Carfilzomib cancer drug F007 / 0129
Carfilzomib cancer drug, molecular model. Carfilzomib is a proteasome inhibitor that is used in cancer treatment. Atoms are represented as spheres and are colour-coded: hydrogen (white)

Carbidopa Parkinsons disease drug, molecular model. Carbidopa slows the breakdown of the actual Parkinsons disease drug levidopa, thereby making it more effective

Canagliflozin diabetes drug F007 / 0124
Canagliflozin type 2 diabetes drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red), fluorine (dark yellow)

Canagliflozin diabetes drug F007 / 0122
Canagliflozin type 2 diabetes drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red), fluorine (dark yellow)

Canagliflozin diabetes drug F007 / 0123
Canagliflozin type 2 diabetes drug, molecular model. Atoms are represented as spheres and are colour-coded: hydrogen (white), carbon (grey), oxygen (red), fluorine (dark yellow)

Cabozantinib cancer drug F007 / 0121
Cabozantinib cancer drug, molecular model. Cabozantinib is a tyrosine kinase inhibitor drug that is used in cancer treatment

Cabozantinib cancer drug F007 / 0120
Cabozantinib cancer drug, molecular model. Cabozantinib is a tyrosine kinase inhibitor drug that is used in cancer treatment

Cabozantinib cancer drug F007 / 0119
Cabozantinib cancer drug, molecular model. Cabozantinib is a tyrosine kinase inhibitor drug that is used in cancer treatment

For sale as Licensed Images

Choose your image, Select your licence and Download the media

"Exploring the World of Molecules: The Ball and Stick Perspective" In this captivating artwork, titled C016 / 8274, we delve into the fascinating realm of molecules through the lens models. Graphene, a revolutionary material with extraordinary properties, takes center stage as its intricate lattice structure is beautifully depicted. Moving beyond graphene's allure, our attention shifts to other remarkable molecules. A capsaicin molecule emerges, responsible for the fiery sensation in chili peppers that tantalizes our taste buds. Oxytocin neurotransmitter molecule follows suit, symbolizing love and bonding within our brains. Januvia diabetes drug molecule comes into view next – a tiny hero combating this widespread disease by regulating blood sugar levels. Cubane molecule then captures our imagination with its unique cubic arrangement of carbon atoms. As we continue on this molecular journey, caffeine's molecular model appears before us - an energizing compound found in coffee that keeps us awake during those long nights. Mescaline hallucinogenic drug molecule adds a touch of intrigue as it represents altered states of consciousness experienced by some. Nanotube technology enters the scene through mesmerizing computer artwork - showcasing its potential to revolutionize various industries with its exceptional strength and conductivity. Fullerene molecule follows closely behind; resembling a soccer ball-like structure composed entirely of carbon atoms. Finally, dopamine neurotransmitter molecule concludes our exploration - highlighting its role in pleasure and reward pathways within our brain chemistry. Through these ball and stick representations, we gain glimpses into the microscopic world that shapes our everyday lives. Each molecule holds secrets waiting to be unraveled – their structures revealing profound insights into nature's building blocks. Let us marvel at their beauty while appreciating their immense impact on science and society alike.